NO971139L - Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler - Google Patents

Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler

Info

Publication number
NO971139L
NO971139L NO971139A NO971139A NO971139L NO 971139 L NO971139 L NO 971139L NO 971139 A NO971139 A NO 971139A NO 971139 A NO971139 A NO 971139A NO 971139 L NO971139 L NO 971139L
Authority
NO
Norway
Prior art keywords
plasmids
pct
preparation
recombinant proteins
modified cells
Prior art date
Application number
NO971139A
Other languages
English (en)
Other versions
NO971139D0 (no
NO320374B1 (no
Inventor
Beatrice Cameron
Joel Crouzet
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO971139L publication Critical patent/NO971139L/no
Publication of NO971139D0 publication Critical patent/NO971139D0/no
Publication of NO320374B1 publication Critical patent/NO320374B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19971139A 1994-09-16 1997-03-12 Ekspresjonsplasmid og fremgangsmate for fremstilling av et rekombinant protein, samt bakterie NO320374B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411049A FR2724665B1 (fr) 1994-09-16 1994-09-16 Procede de production de proteines recombinantes, plasmides et cellules modifiees
PCT/FR1995/001178 WO1996008572A1 (fr) 1994-09-16 1995-09-14 Procede de production de proteines recombinantes, plasmides et cellules modifiees

Publications (3)

Publication Number Publication Date
NO971139L true NO971139L (no) 1997-03-12
NO971139D0 NO971139D0 (no) 1997-03-12
NO320374B1 NO320374B1 (no) 2005-11-28

Family

ID=9466987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971139A NO320374B1 (no) 1994-09-16 1997-03-12 Ekspresjonsplasmid og fremgangsmate for fremstilling av et rekombinant protein, samt bakterie

Country Status (19)

Country Link
US (1) US6143518A (no)
EP (1) EP0781341B1 (no)
JP (1) JP3696247B2 (no)
KR (1) KR100391752B1 (no)
AT (1) ATE405656T1 (no)
AU (1) AU708080B2 (no)
CA (1) CA2197804C (no)
DE (1) DE69535815D1 (no)
DK (1) DK0781341T3 (no)
ES (1) ES2313721T3 (no)
FI (1) FI120238B (no)
FR (1) FR2724665B1 (no)
IL (1) IL115308A (no)
MX (1) MX9701614A (no)
NO (1) NO320374B1 (no)
PT (1) PT781341E (no)
TW (1) TW517086B (no)
WO (1) WO1996008572A1 (no)
ZA (1) ZA957750B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618001D0 (en) 1996-08-29 1996-10-09 Nyfotek As Novel expression vectors
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
EP1022337B1 (en) * 1999-01-20 2006-07-26 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
DE69929638T2 (de) * 1999-01-20 2006-09-21 Bayer Healthcare Ag Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine
DE69940859D1 (de) * 1999-10-19 2009-06-18 Bharat Biotech Int Ltd Expression von rekombinantem, reifem lysostaphin
US9051589B2 (en) * 2005-10-27 2015-06-09 Kaneka Corporation Plasmid vector and transformant stably retaining plasmid
CN101297036B (zh) * 2005-10-27 2013-03-13 株式会社钟化 新质粒载体和稳定保持质粒的转化体
KR20110014199A (ko) 2008-05-13 2011-02-10 클라라산스, 인크. 비강 비염 치료용 재조합 인간 ｃｃ10 및 이의 조성물
RU2554745C2 (ru) 2009-10-15 2015-06-27 Кларассанс, Инк. Рекомбинантный человеческий белок сс10 для лечения гриппа
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
BR102014014502B1 (pt) * 2014-06-13 2020-09-15 Ouro Fino Saúde Animal Ltda Vetor de expressão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
FR2661188B1 (fr) * 1990-04-24 1994-07-22 Rhone Poulenc Sante Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.

Also Published As

Publication number Publication date
FI120238B (fi) 2009-08-14
AU708080B2 (en) 1999-07-29
FR2724665B1 (fr) 1996-12-20
IL115308A0 (en) 1995-12-31
DE69535815D1 (de) 2008-10-02
WO1996008572A1 (fr) 1996-03-21
CA2197804C (fr) 2010-11-16
CA2197804A1 (fr) 1996-03-21
JP3696247B2 (ja) 2005-09-14
TW517086B (en) 2003-01-11
FI971100A0 (fi) 1997-03-14
DK0781341T3 (da) 2009-01-05
FR2724665A1 (fr) 1996-03-22
EP0781341A1 (fr) 1997-07-02
JPH10505746A (ja) 1998-06-09
IL115308A (en) 2009-07-20
EP0781341B1 (fr) 2008-08-20
MX9701614A (es) 1997-06-28
US6143518A (en) 2000-11-07
NO971139D0 (no) 1997-03-12
ZA957750B (en) 1996-04-24
NO320374B1 (no) 2005-11-28
ATE405656T1 (de) 2008-09-15
KR100391752B1 (ko) 2003-10-22
ES2313721T3 (es) 2009-03-01
AU3475495A (en) 1996-03-29
PT781341E (pt) 2008-11-20
FI971100A (fi) 1997-03-14

Similar Documents

Publication Publication Date Title
DK0575443T3 (da) Ærteproteinhydrolysat, fremgangsmåde til dets fremstilling og anvendelse deraf
NO950534D0 (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
DE69323879D1 (de) Herstellung von rekombinanten, menschlichem lactoferrin
NO971139L (no) Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler
DK0473724T3 (da) Et humant cytokin, interleukin-9
IL124831A0 (en) Ob protein derivatives having prolonged half-life
HU9200548D0 (en) Improved activity process of recombined proteins
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
FI942442A0 (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
MY103362A (en) Production of proteins in active forms
DK0652903T3 (da) Nyt humant rekombinant gammainterferon
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU637589B2 (en) Ancrod proteins, their production and use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees